RESEARCHER PROFILE
Tomohiro Takeda
← Back to Kansai University of Health Sciences
T
Kansai University of Health Sciences
Tomohiro Takeda works in Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms, Asthma and respiratory diseases, Hemophilia Treatment and Research, IL-33, ST2, and ILC Pathways. Recorded institutional associations include Japanese Red Cross Medical Center, Kansai University of Health Sciences.
24Publications
345Citations
10H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Platelets constitutively express IL-33 protein and modulate eosinophilic airway inflammation
2016 · 69 citationsAcquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder
2014 · 62 citationsAnaphylaxis to Polyvinylpyrrolidone in Povidone-Iodine for Impetigo Contagiosum in a Boy with Atopic Dermatitis
2008 · 57 citationsRecent advances in understanding the roles of blood platelets in the pathogenesis of allergic inflammation and bronchial asthma
2017 · 34 citationsExpression of coagulation factors from murine induced pluripotent stem cell-derived liver cells
2011 · 21 citationsExamination of the Percentage of Immature Platelet Fraction in Term and Preterm Infants at Birth
2013 · 15 citationsDirect platelet adhesion potentiates group 2 innate lymphoid cell functions
2021 · 15 citationsRobust production of IL-33 and TSLP by lung endothelial cells in response to low-dose dsRNA stimulation
2020 · 13 citationsCo-infection with Legionella and SARS-CoV-2: a case report
2021 · 12 citationsInhibition of PAR4 Signaling Mediates Ethanol‐Induced Attenuation of Platelet Function In Vitro
2006 · 11 citationsElevation of B cell-activating factor belonging to the tumour necrosis family family (BAFF) in haemophilia A patients with inhibitor
2009 · 7 citationsFactor VIII-Mediated Global Hemostasis in the Absence of von Willebrand Factor
2007 · 5 citationsAlterations of T cell receptor Vβ repertoire of CD8 T lymphocytes in immune tolerance induction in two hemophilia A patients with inhibitors
2011 · 5 citationsEnhancement of Tissue Factor Expression in Monocyte-Derived Dendritic Cells by Pentraxin 3 and Its Modulation by C1 Esterase Inhibitor
2019 · 5 citationsvon Willebrand Factor Protects Ca2+-Dependent Structure of the Factor VIII Light Chain.
2005 · 5 citationsExperimental hypercoagulable state induced by tissue factor expression in monocyte-derived dendritic cells and its modulation by C1 inhibitor
2018 · 4 citationsRepression of Factor VIII Inhibitor Development with Apoptotic Factor VIII-Expressing Embryonic Stem Cells
2013 · 2 citationsPlatelets Constitutively Express Interleukin-33 Protein
2014 · 1 citationsSequential Gene Expression Analysis of Coagulation Factors and Proteaseactivated Receptors in Hematopoietic Lineage Development
2014 · 1 citationsDuration of noninvasive respiratory support in preterm infants: Association with gestational age and risk factors for delayed weaning
2025 · 1 citationsCorrigendum to “Increased thrombin generation potential in patients with chronic spontaneous urticaria” [Allergol Int 64 (1) (2015) 96–98]
2015 · 0 citationsHuman lung endothelial cells produce IL-33 and TSLP simultaneously after dsRNA stimulation
2018 · 0 citationsBlood-Circulating Type 2 Follicular Helper T Cells in Pediatric Allergy Patients
2020 · 0 citationsValidation of a candidate international harmonisation protocol‐compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component
2025 · 0 citations